Argus Research Keeps Their Buy Rating on Invesco (IVZ)We are reaffirming our BUY rating on Invesco Ltd. (NYSE: IVZ) following the company’s second-quarter results. Net long-term inflows were healthy at $15.6 billion in 2Q, considering market turmoil, and have been positive for the past eight consecutive quarters. In addition, the company continued to show margin expansion, with adjusted operating income up 3% and the operating margin expanding 30 basis points in 2Q, compared to the prior year. IVZ has also continued to strengthen its balance sheet while returning capital to shareholders. In our view, Invesco remains in show-me mode with investors, requiring strong execution with respect to leveraging Oppenheimer synergies, maintaining net inflows for long-term products, and con- trolling costs.